Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00584 lonafarnib (Zokinvy)PayerPolicy · BCBSLA-00584-15001938B3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00583 Temporomandibular Joint DysfunctionPayerPolicy · BCBSLA-00583-67C8E481BA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00582 Ergotamine/Dihydroergotamine ProductsPayerPolicy · BCBSLA-00582-318661CB88 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00581 Topical AntipruriticsPayerPolicy · BCBSLA-00581-2854601BE4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00580 Topical AnestheticsPayerPolicy · BCBSLA-00580-E463F51C6E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00579 Topical Actinic Keratosis ProductsPayerPolicy · BCBSLA-00579-035E96C6EB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00578 Cognitive RehabilitationPayerPolicy · BCBSLA-00578-A02F41C74D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00577 Laboratory Testing Investigational ServicesPayerPolicy · BCBSLA-00577-427ED888D2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00576 Transcatheter Pulmonary Valve ImplantationPayerPolicy · BCBSLA-00576-BB198BE01C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00575 Basal Insulin/Glucagon Like Peptide (GLP)-1 Agonist Combination Products--Retired PolicyPayerPolicy · BCBSLA-00575-8B4076D09E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00574 Minimally Invasive Ablation Procedures for Morton and Other Peripheral NeuromasPayerPolicy · BCBSLA-00574-4B46F5CA06 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00573 abaloparatide (Tymlos)PayerPolicy · BCBSLA-00573-EB3EE689B1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00572 Bioengineered Skin and Soft Tissue SubstitutesPayerPolicy · BCBSLA-00572-AA63B965F3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00571 Transanal Radiofrequency Treatment of Fecal Incontinence - Retired PolicyPayerPolicy · BCBSLA-00571-E2EEC9329A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00570 Cardiac Rehabilitation in the Outpatient SettingPayerPolicy · BCBSLA-00570-B580391BAB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00569 Microwave Tumor AblationPayerPolicy · BCBSLA-00569-B799912519 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00568 Select Topical Rosacea ProductsPayerPolicy · BCBSLA-00568-AFBAAF81BB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00567 dupilumab (Dupixent)PayerPolicy · BCBSLA-00567-2DC824F74E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00566 carbinoxamine 6mg tablets (Ryvent, generics)PayerPolicy · BCBSLA-00566-5FF5BEBFAE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00565 Daxbia (cephalexin)- Retired PolicyPayerPolicy · BCBSLA-00565-C0DE3B6628 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00564 Select Dexamethasone PacksPayerPolicy · BCBSLA-00564-D52A0AC03A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00562 Molecular Testing in the Management of Pulmonary Nodules- Retired PolicyPayerPolicy · BCBSLA-00562-E46A571357 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00561 Bone Graft Substitutes and Bone Morphogenetic Proteins-Retired policyPayerPolicy · BCBSLA-00561-AD3C047F3F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00560 bezlotoxumab (Zinplava)PayerPolicy · BCBSLA-00560-464FC2CA2B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00559 ocrelizumab (Ocrevus) ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo)PayerPolicy · BCBSLA-00559-331CD47078 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00558 Sacroiliac Joint Fusion (Percutaneous/Minimally Invasive Techniques)-Retired PolicyPayerPolicy · BCBSLA-00558-939A591B06 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00555 telotristat (Xermelo)PayerPolicy · BCBSLA-00555-C1D07CDAD4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00549 Intravitreal and Suprachoroidal Corticosteroid ProductsPayerPolicy · BCBSLA-00549-E03E3A5A6C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00542 Exon Skipping Therapies for Duchenne Muscular DystrophyPayerPolicy · BCBSLA-00542-FA6129537A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00536 Genetic Testing for Developmental Delay/Intellectual Disability, Autism Sprectrum Disorder, and Congenital Anomalies- Retired PolicyPayerPolicy · BCBSLA-00536-2B5F7A2401 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00533 Select Naloxone Injectable ProductsPayerPolicy · BCBSLA-00533-1BC01D8F60 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00503 Ablation of Peripheral Nerves to Treat PainPayerPolicy · BCBSLA-00503-B7395FF3BA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00497 Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)- Retired PolicyPayerPolicy · BCBSLA-00497-B7BC17AEFC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00495 Computed Tomography Perfusion Imaging of the Brain-Retired PolicyPayerPolicy · BCBSLA-00495-5DE15218BB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00489 Genetic Testing for Limb-Girdle Muscular Dystrophies- Retired PolicyPayerPolicy · BCBSLA-00489-4BF24A39B9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00488 Identification of Microorganisms Using Nucleic Acid Probes - Retired PolicyPayerPolicy · BCBSLA-00488-D57055E17C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00485 Drug Eluting Sinus Stents and Implants for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinonasal PolyposisPayerPolicy · BCBSLA-00485-A5A27DF5DE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00460 droxidopa (Northera, generics)PayerPolicy · BCBSLA-00460-2A43623656 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00458 Amniotic Membrane and Amniotic FluidPayerPolicy · BCBSLA-00458-F2E4E72972 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00452 Molecular Analysis (Including Liquid Biopsy) for Targeted Therapy or Immunotherapy of Non-Small-Cell Lung Cancer- Retired PolicyPayerPolicy · BCBSLA-00452-5875B0F727 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00446 Proteomic Testing for Systemic Therapy in Non-Small-Cell Lung Cancer - Retired PolicyPayerPolicy · BCBSLA-00446-B4EAC2495D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00423 Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapy and Immunotherapy- Retired PolicyPayerPolicy · BCBSLA-00423-33A2C64CCC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00411 Liver Transplant and Combined Liver-Kidney TransplantPayerPolicy · BCBSLA-00411-2BB5F4A10E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00405 cysteamine Delayed Release Capsules, Oral Granules (Procysbi)PayerPolicy · BCBSLA-00405-36F48C1EC0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00402 Genetic Testing for Diagnosis and Management of Mental Health Conditions- Retired PolicyPayerPolicy · BCBSLA-00402-192EE12817 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00399 Genetic Testing for Macular Degeneration- Retired PolicyPayerPolicy · BCBSLA-00399-E956A359A5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00394 Genetic Testing for Hereditary Pancreatitis- Retired PolicyPayerPolicy · BCBSLA-00394-8B9966380F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00376 Dimethyl Fumarate (Tecfidera) - Retired PolicyPayerPolicy · BCBSLA-00376-F9ED16A3F3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00368 Melanoma VaccinesPayerPolicy · BCBSLA-00368-EA90380D30 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00366 Mechanical Embolectomy for Treatment of Acute Stroke - Retired PolicyPayerPolicy · BCBSLA-00366-B8399A0F8F | New policy |
|---|